Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03CVV
|
|||
| Former ID |
DIB005329
|
|||
| Drug Name |
Anisperimus
|
|||
| Synonyms |
LF-150195; LF-150969
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Immune System disease [ICD-11: 4A01-4B41; ICD-10: T86.0] | Discontinued in Phase 2 | [1] | |
| Company |
Fournier Pharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H39N7O3
|
|||
| Canonical SMILES |
CC(CCNCCCCNC(=O)OCC(=O)NCCCCCCN=C(N)N)N
|
|||
| InChI |
1S/C18H39N7O3/c1-15(19)8-13-22-9-6-7-12-25-18(27)28-14-16(26)23-10-4-2-3-5-11-24-17(20)21/h15,22H,2-14,19H2,1H3,(H,23,26)(H,25,27)(H4,20,21,24)/t15-/m1/s1
|
|||
| InChIKey |
PZDPVSFZTKORSP-OAHLLOKOSA-N
|
|||
| CAS Number |
CAS 170368-04-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009259) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.